DAY ONE BIOPHARMACEUTICALS
DEAD

Serial Number

98191847

Owner

DAY ONE BIOPHARMACEUTICALS, INC.

Attorney

Connie L. Ellerbach

Filing Date

Sep 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DAY ONE BIOPHARMACEUTICALS Trademark

Serial Number: 98191847

DAY ONE BIOPHARMACEUTICALS is a trademark filed by DAY ONE BIOPHARMACEUTICALS, INC. on September 21, 2023. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

DAY ONE BIOPHARMACEUTICALS, INC. (17 trademarks)

1800 Sierra Point Parkway, Suite 200
Brisbane, CA 94005

Entity Type: 03

Trademark Details

Filing Date

September 21, 2023

Registration Date

Not Registered

Goods & Services

Providing pharmaceutical information and support services, namely, providing product information and support services regarding the dosing, administration, and clinical profile of the prescription drugs and treatment of diseases; healthcare services, namely, disease management programs; providing medical information regarding the treatment, and diagnosis of diseases; providing medical information regarding pharmaceutical products for the treatment of diseases; providing medical information and advice for healthcare service providers and patients in connection with pharmaceutical product treatment; healthcare services, namely, providing cancer treatment medical information to physicians, health care professionals, and patients; medical information services, namely, providing medical information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing a website featuring health information in the field of tumors and cancer; providing a website featuring health information in the field of pediatric low-grade glioma; providing medical information regarding the treatment and diagnosis of tumors and cancer; providing medical information regarding the treatment and diagnosis of pediatric low-grade glioma; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with tumors and cancer; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with pediatric low-grade glioma; medical information services regarding tumors and cancer, and pediatric low-grade glioma; providing information regarding the treatment, and diagnosis of diseases; providing medical information relating to prescription drugs

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 11, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 11, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 9, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 9, 2025 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 10, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 10, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 10, 2025 COAR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 10, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 10, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 10, 2025 CNFR
DIVISIONAL PROCESSING COMPLETE
Oct 15, 2024 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 11, 2024 AITU
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2024 TEME
DIVISIONAL REQUEST RECEIVED
Sep 9, 2024 DRRR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2024 TROA
TEAS REQUEST TO DIVIDE RECEIVED
Sep 9, 2024 ERTD
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 6, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 6, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 8, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 10, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2023 NWOS
NEW APPLICATION ENTERED
Sep 25, 2023 NWAP